Attached files

file filename
8-K - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES - SILICON LABORATORIES INC.a12-24729_18k.htm

Exhibit 99

 

 

SILICON LABORATORIES REPORTS RECORD REVENUE

Company Delivers Strong Quarterly Performance and Outlook—

 

AUSTIN, Texas — Oct. 24, 2012 — Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported record third quarter revenue of $149.5 million, an impressive 25 percent increase compared to the third quarter of 2011.  The company believes market share gains across the portfolio and record design win activity are enabling the business to outperform the end markets.

 

Financial Highlights

 

Third quarter revenue was up ten percent sequentially due to both organic growth and the additional revenue from an acquisition completed during the quarter. On a GAAP-basis, gross margin was 57.9 percent, which included one-time charges associated with the acquisition.  R&D investment increased to $34.8 million, and SG&A expense decreased to $24.5 million. SG&A expense declined primarily due to an $8.1 million gain from the purchase of the company’s headquarters. Resulting GAAP operating income increased to 18.2 percent. Diluted GAAP earnings per share declined to $0.24 and included other charges related to the acquisition of Ember and a net gain from the purchase of the headquarters buildings.

 

The following non-GAAP results exclude the impact of stock compensation and other one-time items. Gross margin was 61.0 percent for the quarter. Operating expenses decreased to 39.1 percent of sales. R&D increased to $31.7 million, and SG&A increased to $26.7 million due to the acquisition and increased variable compensation. Operating income, therefore, was better than expected at 21.9 percent of revenue. Strong revenue growth and operating performance resulted in significant earnings leverage. Diluted earnings per share for the quarter was 61 cents, a 20 percent sequential increase. Reconciling charges are set forth in the financial measures table included below.

 



 

The company repurchased $14.9 million of stock and ended the quarter with $285 million in cash, cash equivalents and investments due to continued healthy cash flow from operations.

 

Business Highlights

 

All of the company’s major product categories, Access, Broadcast and Broad-based, grew sequentially again in the third quarter.  The company believes it is benefiting from growth trends in energy efficiency, the Internet of Everything, and the explosion in demand for bandwidth, all of which drive an increasing need for mixed-signal ICs.

 

The Broad-based business was up 15 percent as the company’s microcontroller (MCU) products posted record revenue. The increase, driven by both organic growth and the acquisition of ZigBee® wireless products, resulted from market share gains in communications infrastructure, consumer devices, smart energy, home automation and security.  The company’s power products benefited from customers’ redesigns of power systems and grew 20 percent sequentially.

 

The Broadcast business increased in both audio and video as consumer equipment makers continued to build ahead of the holidays.  Design win traction remains very strong, with the company’s video products closing on the majority of 2013 TV models, enabling continued share gains into next year. The Access products also posted sequential growth due to new ramps in PBX systems, voice over cable and Power over Ethernet applications.

 

“Our Broad-based business has achieved critical mass, and with double-digit annual growth rates, it is on track to be the majority of our business as we exit the year,” said Tyson Tuttle, president and CEO of Silicon Laboratories. “We’ve aligned our product focus to capitalize on the most important trends impacting mixed-signal ICs, and I feel good about extending the breadth and quality of the growth we’re seeing in the business into 2013.”

 

The company expects revenue for the fourth quarter to be in the range of $145 to $150 million.

 



 

Webcast and Conference Call

 

A conference call discussing the quarterly results will follow this press release at 7:30 a.m. Central time. An audio webcast will be available simultaneously on Silicon Laboratories’ website under Investor Relations (www.silabs.com).  A replay will be available after the call at the same website listed above or by calling 1 (855) 859-2056 or +1 (404) 537-3406 (international) and by entering 39712936. The replay will be available through November 7.

 

About Silicon Laboratories Inc.

 

Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories’ diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories, please visit www.silabs.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements based on Silicon Laboratories’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; inventory-related risks; risks associated with acquisitions; difficulties managing international activities; difficulties managing our manufacturers and subcontractors; risks that Silicon Laboratories may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel;

 



 

risks associated with divestitures; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Laboratories’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories’ filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Silicon Laboratories Inc., Shannon Pleasant, (512) 464 9254, shannon.pleasant@silabs.com

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 29,
2012

 

October 1,
2011

 

September 29,
2012

 

October 1,
2011

 

Revenues

 

$

149,461

 

$

119,100

 

$

410,833

 

$

364,933

 

Cost of revenues

 

62,968

 

46,203

 

166,442

 

143,666

 

Gross margin

 

86,493

 

72,897

 

244,391

 

221,267

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

34,768

 

31,715

 

101,943

 

101,248

 

Selling, general and administrative

 

24,495

 

27,254

 

82,075

 

85,168

 

Operating expenses

 

59,263

 

58,969

 

184,018

 

186,416

 

Operating income

 

27,230

 

13,928

 

60,373

 

34,851

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

243

 

388

 

1,103

 

1,432

 

Interest expense

 

(234

)

(4

)

(299

)

(14

)

Other income (expense), net

 

(161

)

(81

)

807

 

292

 

Income before income taxes

 

27,078

 

14,231

 

61,984

 

36,561

 

Provision for income taxes

 

17,054

 

2,976

 

17,131

 

13,894

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

10,024

 

$

11,255

 

$

44,853

 

$

22,667

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.24

 

$

0.26

 

$

1.06

 

$

0.52

 

Diluted

 

$

0.24

 

$

0.26

 

$

1.04

 

$

0.50

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

41,735

 

42,834

 

42,279

 

43,902

 

Diluted

 

42,520

 

43,919

 

43,261

 

45,305

 

 



 

 Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

 

 

Three Months Ended
September 29, 2012

 

Non-GAAP Income
Statement Items

 

GAAP
Measure

 

GAAP
Percent of
Revenue

 

Stock
Compensation
Expense *

 

Termination
Costs

 

Acquisition 
Related
 Items

 

Headquarters
Purchase
Items

 

Non-
GAAP
Measure

 

Non-
GAAP
Percent of
Revenue

 

Revenues

 

$

149,461

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

86,493

 

57.9

%

$

261

 

$

 

$

4,466

 

$

 

$

91,220

 

61.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

34,768

 

23.3

%

3,039

 

 

 

 

31,729

 

21.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

24,495

 

16.4

%

4,096

 

1,428

 

358

 

(8,113

)

26,726

 

17.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

59,263

 

39.7

%

7,135

 

1,428

 

358

 

(8,113

)

58,455

 

39.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

27,230

 

18.2

%

7,396

 

1,428

 

4,824

 

(8,113

)

32,765

 

21.9

%

 

 

 

Three Months Ended
September 29, 2012

 

Non-GAAP Diluted
Earnings Per Share

 

GAAP
Measure

 

Stock
Compensation
Expense *

 

Termination
Costs

 

Acquisition
Related
Items

 

Headquarters
Purchase
Items

 

Non-
GAAP
Measure

 

Net income

 

$

10,024

 

$

6,595

 

$

1,136

 

$

13,651

 

$

(5,274

)

$

26,132

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted shares outstanding

 

42,520

 

 

 

 

 

 

 

 

 

42,520

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.24

 

 

 

 

 

 

 

 

 

$

0.61

 

 


*  Excludes stock compensation recognized in connection with terminations costs for our former CEO.

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

 

September 29,
2012

 

December 31,
2011

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

125,505

 

$

94,964

 

Short-term investments

 

148,573

 

212,526

 

Accounts receivable, net of allowances for doubtful accounts of $789 at September 29, 2012 and $725 at December 31, 2011

 

75,749

 

55,351

 

Inventories

 

42,523

 

34,778

 

Deferred income taxes

 

15,870

 

11,563

 

Prepaid expenses and other current assets

 

36,735

 

43,867

 

Total current assets

 

444,955

 

453,049

 

Long-term investments

 

11,418

 

17,477

 

Property and equipment, net

 

136,321

 

25,141

 

Goodwill

 

130,069

 

115,489

 

Other intangible assets, net

 

94,611

 

60,005

 

Other assets, net

 

37,669

 

34,830

 

Total assets

 

$

855,043

 

$

705,991

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

35,476

 

$

26,354

 

Current portion of long-term debt

 

5,000

 

 

Accrued expenses

 

41,441

 

30,857

 

Deferred income on shipments to distributors

 

30,903

 

24,962

 

Income taxes

 

3,339

 

665

 

Total current liabilities

 

116,159

 

82,838

 

Long-term debt

 

95,000

 

 

Other non-current liabilities

 

22,663

 

24,214

 

Total liabilities

 

233,822

 

107,052

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock—$0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock—$0.0001 par value; 250,000 shares authorized; 41,706 and 42,068 shares issued and outstanding at September 29, 2012 and December 31, 2011, respectively

 

4

 

4

 

Additional paid-in capital

 

 

14,749

 

Retained earnings

 

622,098

 

586,653

 

Accumulated other comprehensive loss

 

(881

)

(2,467

)

Total stockholders’ equity

 

621,221

 

598,939

 

Total liabilities and stockholders’ equity

 

$

855,043

 

$

705,991

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Nine Months Ended

 

 

 

September 29,
2012

 

October 1,
2011

 

Operating Activities

 

 

 

 

 

Net income

 

$

44,853

 

$

22,667

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

Depreciation of property and equipment

 

10,247

 

10,119

 

Net gain on the purchase of property and equipment

 

(8,457

)

 

Amortization of other intangible assets and other assets

 

11,001

 

8,570

 

Stock-based compensation expense

 

23,796

 

27,224

 

Income tax benefit from employee stock-based awards

 

2,301

 

2,301

 

Excess income tax benefit from employee stock-based awards

 

(2,470

)

(2,111

)

Deferred income taxes

 

5,024

 

2,011

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(18,470

)

(11,581

)

Inventories

 

(5,994

)

1,670

 

Prepaid expenses and other assets

 

13,283

 

227

 

Accounts payable

 

9,113

 

871

 

Accrued expenses

 

(797

)

819

 

Deferred income on shipments to distributors

 

5,267

 

1,495

 

Income taxes

 

(4,378

)

1,287

 

Net cash provided by operating activities

 

84,319

 

65,569

 

Investing Activities

 

 

 

 

 

Purchases of available-for-sale investments

 

(138,822

)

(113,784

)

Proceeds from sales and maturities of marketable securities

 

209,972

 

166,262

 

Purchases of property and equipment

 

(99,720

)

(7,472

)

Purchases of other assets

 

(6,146

)

(891

)

Acquisition of businesses, net of cash acquired

 

(71,852

)

(27,262

)

Net cash provided by (used in) investing activities

 

(106,568

)

16,853

 

Financing Activities

 

 

 

 

 

Proceeds from issuance of common stock, net of shares withheld for taxes

 

3,035

 

2,320

 

Excess income tax benefit from employee stock-based awards

 

2,470

 

2,111

 

Repurchases of common stock

 

(51,040

)

(110,063

)

Proceeds from issuance of long-term debt, net

 

98,325

 

 

Payments on debt

 

 

(7,174

)

Net cash provided by (used in) financing activities

 

52,790

 

(112,806

)

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

30,541

 

(30,384

)

Cash and cash equivalents at beginning of period

 

94,964

 

138,567

 

Cash and cash equivalents at end of period

 

$

125,505

 

$

108,183

 

 

 #  #  #